Cell-penetrating peptides as vectors for delivery of nucleic acids

Cell-Penetrating Peptides: Processes and Applications

Volumn , Issue , 2002, Pages 347-363

  Valkna, Andres ^a   Soomets, Ursel ^b   Langel, Ülo ^c  

^a NATIONAL INSTITUTE OF CHEMICAL PHYSICS AND BIOPHYSICS   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746888725     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Delihas, N., Rokita, S.E., and Zheng, P., Natural antisense RNA/target RNA interactions:possible models for antisense oligonucleotide drug design, Nat. Biotechnol., 15, 751, 1997.
2. Morishita, R. et al., A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo, Proc. Natl. Acad. Sci. U.S.A., 92, 5855, 1995.
3. Feeley, B.T. et al., Nuclear factor-kappaB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents, Transplantation, 70, 1560, 2000.
4. Ishibashi, H. et al., Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities, Cancer Res., 60, 6531, 2000.
5. Kawamura, I. et al., Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice, Gene Ther., 8, 905, 2001.
6. Tomita, N. et al., Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB, Exp. Nephrol., 9, 181, 2001.
7. Park, Y.G. et al., Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide, Biochem. Biophys. Res. Commun., 281, 1213, 2001.
8. Deshpande, D. et al., Enhanced cellular uptake of oligonucleotides by EGF receptormediated endocytosis in A549 cells, Pharm. Res., 13, 57, 1996.
9. Nakai, D. et al., Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15, J. Pharmacol. Exp. Ther., 278, 1362, 1996.
10. Bennet, R.M. et al., The production and characterization of murine monoclonal antibodies to a DNA receptor on human leukocytes, J. Immunol., 140, 2937, 1988.
11. Hefeneider, S.H. et al., Identification of a cell-surface DNA receptor and its association with systemic lupus erythematosus, J. Invest. Dermatol., 94, 79S, 1990.
12. Francolini, M. et al., Evidence for nuclear internalization of exogenous DNA into mammalian sperm cells, Mol. Reprod. Dev., 34, 133, 1993.
13. Zamecnik, P. et al., Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes, Proc. Natl. Acad. Sci. U.S.A., 91, 3156, 1994.
14. Goodarzi, G., Watabe, M., and Watabe, K., Binding of oligonucleotides to cell membranes at acidic pH, Biochem. Biophys. Res. Commun., 181, 1343, 1991.
15. Akhtar, S. et al., The influence of polarized epithelial (Caco-2) cell differentiation on the cellular binding of phosphodiester and phosphorothioate oligonucleotides, Antisense Nucleic Acid Drug Dev., 6, 197, 1996.
16. Yakubov, L.A. et al., Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. U.S.A., 86, 6454, 1989.
17. Wu-Pong, S., Weiss, T.L., and Hunt, C.A., Antisense c-myc oligonucleotide cellular uptake and activity, Antisense Res. Dev., 4, 155, 1994.
18. Wu-Pong, S., Weiss, T.L., and Hunt, C.A., Antisense c-myc oligodeoxyribonucleotide cellular uptake, Pharm. Res., 9, 1010, 1992.
19. Nestle, F.O. et al., Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes, J. Invest. Dermatol., 103, 569, 1994.
20. Noonberg, S.B., Garovoy, M.R., and Hunt, C.A., Characteristics of oligonucleotide uptake in human keratinocyte cultures, J. Invest. Dermatol., 101, 727, 1993.
21. Shoji, Y. et al., Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages, Nucleic Acids Res., 19, 5543, 1991.
22. Giles, R.V., Spiller, D.G., and Tidd, D.M., Chimeric oligodeoxynucleotide analogues:enhanced cell uptake of structures which direct ribonuclease H with high specificity, Anticancer Drug Des., 8, 33, 1993.
23. Smith-Arica, J.R. and Bartlett, J.S., Gene therapy: recombinant adeno-associated virus vectors, Curr. Cardiol. Rep., 3, 43, 2001.
24. Riviere, I. et al., Retroviral-mediated gene transfer in primary murine and human Tlymphocytes, Mol. Biotechnol., 15, 133, 2000.
25. Kompella, U.B. and Koushik, K., Preparation of drug delivery systems using supercritical fluid technology, Crit. Rev. Ther. Drug Carrier Syst., 18, 173, 2001.
26. Chandran, S., Roy, A., and Mishra, B., Recent trends in drug delivery systems:liposomal drug delivery system - preparation and characterisation, Indian J. Exp. Biol., 35, 801, 1997.
27. Uwai, Y. et al., Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney, FEBS Lett., 438, 321, 1998.
28. Krieg, A.M. et al., Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy, Proc. Natl. Acad. Sci. U.S.A., 90, 1048, 1993.
29. Letsinger, R.L. et al., Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture, Proc. Natl. Acad. Sci. U.S.A., 86, 6553, 1989.
30. Chow, T.Y., Juby, C., and Brousseau, R., Specific targeting of antisense oligonucleotides to neutrophils, Antisense Res. Dev., 4, 81, 1994.
31. Janout, V. et al., Evidence for highly cooperative binding between molecular umbrella-spermine conjugates and DNA, Bioconjug. Chem., 8, 891, 1997.
32. Kalkbrenner, F. et al., Nuclear application of antisense oligonucleotides by microinjection and ballistomagnetic transfer to identify G protein heterotrimers activating phospholipase C, Methods Mol. Biol., 83, 203, 1997.
33. Swartz, M. et al., Sparking new frontiers: using in vivo electroporation for genetic manipulations, Dev. Biol., 233, 13, 2001.
34. Wu, C.H. and Wu, G.Y., Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines, Gastroenterology, 114, 1304, 1998.
35. Wu, G.Y. and Wu, C.H., Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides, J. Biol. Chem., 267, 12436, 1992.
36. Gottschalk, S. et al., Folate receptor mediated DNA delivery into tumor cells: photosomal disruption results in enhanced gene expression, Gene Ther., 1, 185, 1994.
37. Pooga, M. et al., Cell penetration by transportan, FASEB J., 12, 67, 1998.
38. Schwarze, S.R. et al., In vivo protein transduction: delivery of a biologically active protein into the mouse, Science, 285, 1569, 1999.
39. Allinquant, B. et al., Down regulation of amyloid precursor protein inhibits neurite outgrowth in vitro, J. Cell. Biol., 128, 919, 1995.
40. Derossi, D. et al., The third helix of the Antennapedia homeodomain translocates through biological membranes, J. Biol. Chem., 269, 10444, 1994.
41. Troy, C.M. et al., Down regulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway, J. Neurosci., 16, 253, 1996.
42. Simmons, C.G. et al., Synthesis and membrane permeability of PNA-peptide conjugates, Bioorg. Med. Chem. Lett., 7, 3001, 1997.
43. Nielsen, P.E. et al., Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide, Science, 254, 1497, 1991.
44. Pooga, M. et al., Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo, Nat. Biotechnol., 16, 857, 1998.
45. Aldrian-Herrada, G. et al., A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons, Nucleic Acids Res., 26, 4910, 1998.
46. Astriab-Fisher, A. et al., Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates, Biochem. Pharmacol., 60, 83, 2000.
47. Villa, R. et al., Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells, FEBS Lett., 473, 241, 2000.
48. Kokunai, T. et al., Overcoming of radioresistance in human gliomas by p21WAF1/CIP1 antisense oligonucleotide, J. Neurooncol., 51, 111, 2001.
49. Eguchi, A. et al., Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells, J. Biol. Chem., 276, 26204, 2001.
50. Galloway, C.J. et al., Analysis of endosome and lysosome acidification in vitro, Methods Enzymol., 157, 601, 1988.
51. Anderson, H.A., Chen, Y., and Norkin, L.C., Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae, Mol. Biol. Cell, 7, 1825, 1996.
52. Orlandi, P.A. and Fishman, P.H., Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains, J. Cell Biol., 141, 905, 1998.
53. Beletskii, A. et al., PNA interference mapping demonstrates functional domains in the noncoding RNA Xist, Proc. Natl. Acad. Sci. U.S.A., 98, 9215, 2001.
54. Lin, Y.Z. et al., Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence, J. Biol. Chem., 270, 14255, 1995.
55. Chaloin, L. et al., Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties, Biochem. Biophys. Res. Commun., 243, 601, 1998.
56. Antopolsky, M. et al., Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties, Bioconjug. Chem., 10, 598, 1999.
57. Morris, M.C. et al., A new peptide vector for efficient delivery of oligonucleotides into mammalian cells, Nucleic Acids Res., 25, 2730, 1997.
58. Vidal, P. et al., New strategy for RNA vectorization in mammalian cells. Use of a peptide vector, C.R. Acad. Sci. III, 320, 279, 1997.
59. Morris, M.C. et al., A novel potent strategy for gene delivery using a single peptide vector as a carrier, Nucleic Acids Res., 27, 3510, 1999.
60. Zanta, M.A., Belguise-Valladier, P., and Behr, J.P., Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus, Proc. Natl. Acad. Sci. U.S.A., 96, 91, 1999.
61. Cutrona, G. et al., Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal, Nat. Biotechnol., 18, 300, 2000.
62. Brandén, L.J., Christensson, B., and Smith, C.I., In vivo nuclear delivery of oligonucleotides via hybridizing bifunctional peptides, Gene Ther., 8, 84, 2001.
63. Elmquist, A. et al., VE-Cadherin-derived cell-penetrating peptide, pVEC, with carrier functions, Exp. Cell Res., 269, 237, 2001.
64. Wyman, T.B. et al., Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers, Biochemistry, 36, 3008, 1997.
65. Fominaya, J. et al., An optimized amphiphilic cationic peptide as an efficient nonviral gene delivery vector, J. Gene Med., 2, 455, 2000.
66. Niidome, T. et al., Chain length of cationic alpha-helical peptide sufficient for gene delivery into cells, Bioconjug. Chem., 10, 773, 1999.
67. Niidome, T. et al., Required structure of cationic peptide for oligonucleotide-binding and -delivering into cells, J. Pept. Sci., 6, 271, 2000.
68. Good, L. et al., Bactericidal antisense effects of peptide-PNA conjugates, Nat. Biotechnol., 19, 360, 2001.
69. Vaara, M. and Porro, M., Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria, Antimicrob. Agents Chemother., 40, 1801, 1996.
70. Fisher, K.J. and Wilson, J.M., Biochemical and functional analysis of an adenovirusbased ligand complex for gene transfer, Biochem. J., 299, 49, 1994.
71. Siller-Lopez, F. et al., Truncated active matrix metalloproteinase-8 gene expression in HepG2 cells is active against native type I collagen, J. Hepatol., 33, 758, 2000.
72. Zenke, M. et al., Receptor-mediated endocytosis of transferrin-polycation conjugates:an efficient way to introduce DNA into hematopoietic cells, Proc. Natl. Acad. Sci. U.S.A., 87, 3655, 1990.
73. Midoux, P. et al., Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells, Nucleic Acids Res., 21, 871, 1993.
74. Zhou, X.H., Klibanov, A.L., and Huang, L., Lipophilic polylysines mediate efficient DNA transfection in mammalian cells, Biochim. Biophys. Acta, 1065, 8, 1991.
75. Ramsay, E. et al., Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in vitro, Int. J. Pharm., 210, 97, 2000.
76. Shen, W.C. and Ryser, H.J., Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins, Proc. Natl. Acad. Sci. U.S.A., 75, 1872, 1978.
77. Leonetti, J.P., Degols, G., and Lebleu, B., Biological activity of oligonucleotidepoly (L-lysine) conjugates: mechanism of cell uptake, Bioconjug. Chem., 1, 149, 1990.
78. Sazani, P. et al., Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs, Nucleic Acids Res., 29, 3965, 2001.
79. Sheldon, K. et al., Loligomers: design of de novo peptide-based intracellular vehicles, Proc. Natl. Acad. Sci. U.S.A., 92, 2056, 1995.
80. Singh, D. et al., Penetration and intracellular routing of nucleus-directed peptidebased shuttles (loligomers) in eukaryotic cells, Biochemistry, 37, 5798, 1998.
81. Lindberg, M. et al., Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR, Biochemistry, 40, 3141, 2001.